0001127602-21-000254.txt : 20210104
0001127602-21-000254.hdr.sgml : 20210104
20210104192121
ACCESSION NUMBER: 0001127602-21-000254
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210101
FILED AS OF DATE: 20210104
DATE AS OF CHANGE: 20210104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Brien Stephanie Monaghan
CENTRAL INDEX KEY: 0001720907
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 21503398
MAIL ADDRESS:
STREET 1: C/O MORNINGSIDE TECHNOLOGY ADVISORY, LLC
STREET 2: 1188 CENTRE STREET
CITY: NEWTON CENTRE
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-01-01
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001720907
O'Brien Stephanie Monaghan
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Stock Option (Right to Buy)
57.20
2021-01-01
4
A
0
27600
0
A
2030-12-31
Common Stock
27600
27600
D
This option was granted 01/01/2021. The option vests quarterly over 1 year on the last day of each quarter from grant date.
/s/ David Watson, attorney-in-fact for Stephanie Monagham O'Brien
2021-01-04